Labiotech.eu

News and Trends 31 Jul 2019

Wellington Partners Raises €210M to Invest in European Life Sciences

VC firm Wellington Partners has raised its fifth fund dedicated to investing in life science companies, with a major focus on those located in German-speaking countries. Wellington Partners has well surpassed its initial target of €150M for its fifth life sciences fund. With a total €210M raised, this new fund is more than double the […]

July 31, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Jul 2019

French Biotech’s Insulin Resistance Treatment Boosted by €67M Series A

The French company Alizé Pharma III has raised a Series A round of €67M to push two peptide drugs into phase I, including a drug treating rare genetic conditions causing insulin resistance. The money will advance Alizé Pharma III’s two preclinical drugs into clinical trials, with phase I trials expected to begin in 2020. One […]

July 31, 2019 - 2 minutesmins - By Jonathan Smith

Interview 30 Jul 2019

The First Approved NASH Therapy?

Genfit is poised to become the first company to get a treatment for NASH to market — something that could happen as early as 2020, should its late 2019 phase III trial results be positive. I spoke to Dean Hum, the current COO and CSO of Genfit, to find out more about the company’s 20-year […]

July 30, 2019 - 6 minutesmins - By Helen Albert

agrosavfe belgium strawberry pesticide fungal

News and Trends 30 Jul 2019

Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides

The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an environmentally friendly crop pesticide inspired by llama antibodies. AgroSavfe will use the funds to develop and manufacture its lead protein fungicide on a commercial scale. The company aims to get approval from the US Environmental Protection Agency and launch the […]

July 30, 2019 - 2 minutesmins - By Jonathan Smith

Expert Advice 30 Jul 2019

How to Build a Winning Life Science Content Marketing Strategy

The data are in. Content works. As the internet matured, buyers in all industries began educating themselves before making a buying decision. When prospects get in touch with you, they’ve likely made up their mind already. How, then, can you affect their decision? “Publish or perish” has been standard advice for scientists since the early […]

July 30, 2019 - 12 minutesmins - By James Mathison

News and Trends 29 Jul 2019

€43M Series C to Launch UK Company’s Home Hemodialysis Kit

Quanta Dialysis Technologies has raised €43.2M ($48M) to fund the commercial launch of a device that makes home hemodialysis more straightforward and economical for kidney failure patients. The UK-based Quanta will use the money to launch its technology in the UK later this year, and also apply for FDA approval. The technology previously obtained a […]

July 29, 2019 - 2 minutesmins - By Jonathan Smith

Startup Scout 26 Jul 2019

This Biotech Makes Food for Space Missions Using Bacteria

Time to head to Helsinki, Finland, this week! We’re visiting Solar Foods, a biotech using bacteria to produce protein-rich flour out of carbon dioxide and water. Mission: To develop a protein-rich powder that can be made with little more than bacteria, electricity and water. This production method could be more efficient and sustainable than traditional […]

July 26, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 25 Jul 2019

French Biotech Aims for Chikungunya Vaccine First with €21M Fundraise

The French vaccine developer Valneva has received a €21M ($23.4M) grant to catch up with the competition in commercializing the first potential vaccine for the chikungunya virus. Coming from the nonprofit Coalition for Epidemic Preparedness Innovations (CEPI), the grant will boost the manufacturing and development of Valneva’s vaccine for the tropical disease chikungunya, which causes […]

July 25, 2019 - 2 minutesmins - By Jonathan Smith

More News! 25 Jul 2019

German Biotech Breath Therapeutics Acquired in Deal Worth up to €500M

The Italian company Zambon has acquired the German biotech Breath Therapeutics for up to €500M, getting hold of its treatment for a rare lung disease known as popcorn lung. The deal includes an upfront payment of €140M and up to €360M upon reaching undisclosed regulatory milestones. Zambon will take over the development of a treatment […]

July 25, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 23 Jul 2019

HIV Drug Suppresses Virus for Almost Two Years When Other Treatments Fail

A first-in-class HIV treatment developed by the UK company ViiV Healthcare has suppressed the virus in people who have become resistant to other antiretroviral drugs, providing protection for at least 96 weeks. The phase III trial tested ViiV Healthcare’s first-in-class drug fostemsavir in 272 HIV-infected people who had failed to respond to approved antiretroviral drugs. […]

July 23, 2019 - 2 minutesmins - By Jonathan Smith

Catherine Pickering iOnctura e1575382680993

Interview 22 Jul 2019

Turning Shelved Drugs into a New Promise for Immuno-Oncology

After working for 12 years at Merck, Catherine Pickering decided to take a risk and create iOnctura, a spin-out company exploring a new application in immuno-oncology for a drug candidate that had been shelved. In the last decade, there has been a massive boom in the development of cancer therapies that use and enhance the […]

July 22, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

rnai rna intereference silence therapeutics mallinckrodt

More News! 19 Jul 2019

Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M

The UK-based biotech Silence Therapeutics has signed a deal worth up to €553M ($693M) with the UK pharma company Mallinckrodt to develop RNA interference (RNAi) therapies for autoimmune diseases. Mallinckrodt will pay Silence Therapeutics €17.8M ($20M) upfront, and up to €600M ($673M) in developmental milestone payments. In exchange, it will get a license for an […]

July 19, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Wellington Partners Raises €210M to Invest in European Life Sciences

French Biotech’s Insulin Resistance Treatment Boosted by €67M Series A

The First Approved NASH Therapy?

Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides

How to Build a Winning Life Science Content Marketing Strategy

€43M Series C to Launch UK Company’s Home Hemodialysis Kit

This Biotech Makes Food for Space Missions Using Bacteria

French Biotech Aims for Chikungunya Vaccine First with €21M Fundraise

German Biotech Breath Therapeutics Acquired in Deal Worth up to €500M

HIV Drug Suppresses Virus for Almost Two Years When Other Treatments Fail

Turning Shelved Drugs into a New Promise for Immuno-Oncology

Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!